Please assess the completion status of the following clinical trial:

Trial Title: Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Healthy adult, female, 18 years of age or older with skin type I-IV;~2. Having at least one suitable treatment area for hair removal with brown hair;~3. Able and willing to comply with the treatment/follow-up schedule and requirements;~4. Able to read, understand and provide written Informed Consent.~5. Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to market preference test enrollment and throughout the course of the study treatment.~Exclusion Criteria:~1. Showing symptoms of hormonal disorders, as per the Investigator's discretion;~2. Use of oral isotretinoin (Accutane®) within 6 months~3. Prior skin treatment with laser or other devices on the same treated areas prior to study enrollment or during the course of the study;~4. History of keloid formation or poor wound healing in a previously injured skin area;~5. Significant skin conditions affecting treated area or inflammatory skin conditions;~6. Open laceration, abrasion, active cold sores or herpes sores on area to be treated;~7. History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications;~8. Having a history of bleeding disorder or taking anticoagulation medications before the washout period, per the package insert, and at the physician's discretion;~9. Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the area to be treated, personal history of melanoma;~10. Significant concurrent illness, such as diabetes, lupus, epilepsy or cardiac disorders, which might be aggravated as a result of treatment;~11. Unable or unlikely to refrain from tanning, including the use of tanning booths, tanning spray or cream, during the course of the evaluation;~12. Tattoos in the treatment areas;~13. Dysplastic nevi in the treatment areas;~14. Participation in a study of another device or drug within 3 month prior to study enrollment or during this study, and as per the Investigator's careful discretion, as long as not contradictory to any of the above criteria;~15. Mentally incompetent, prisoner or evidence of active substance or alcohol abuse;~16. Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study;~17. Allergy or history of an allergy to any topical anesthetic used;~18. Pregnant, expectation of pregnancy, postpartum (\<3 months) or nursing (\<6 weeks);~19. History of livedo reticularis, an autoimmune vascular disease;~20. Hypersensitivity at the treatment site to any agents, solutions, or gel used in the treatment (applies to ET handpiece only), if no alternative exists;

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- HS treatment (Type: EXPERIMENTAL): Treatment with HS handpiece

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete